Learn more about Fosamax (Alendronate)
Fosamax (Generic: Alendronate Sodium) is a common drug prescribed either orally or intravenously for the treatment of Osteoperosis and Pagets's Disease.
Fosamax is a Bisphosphonate. Bisphosphonates block the work of bone cells called osteoclasts, one of two important types of bone cells that are involved in the process of bone remodeling.
During this process, osteoblasts put calcium in the matrix of the bone and make bone stronger, and osteoclasts take calcium away, diminishing the internal strength of the bone.
FDA approval for Fosamax was granted by the FDA in 1995 and was first investigated in March of 2005 for high occurrences of Osteocronosis of the Jaw. View the FDA Reports for more information about their investigation of this dangerous drug.
Osteocronosis of the Jaw, also known as Dead Jaw or rotting of the jaw, is the destruction (necrosis) of bone tissue, often due to an interference with the supply of blood to the bones of the jaw.
see also:
Alveolar Bone Loss
Fosamax linked to Alveolar Bone Loss - Have you been hurt by Fosamax?Are you at risk for Alveolar bone loss? Get a free Fosamax case eval
Fosamax and Cancer Patients
Fosamax and Cancer Patients - Are you at risk?Fosamax and Cancer - Find out if you should be concerned
Learn More
Learn more about Fosamax - Are you at risk? Find out hereLearn more about Fosamax - Dangerous health risks linked with Fosamax


